PMA Options
an e-mail stating that FDA will proceed to resolve any exceptional deficiencies via Interactive Review; orThis document outlines the toxicological approach to drug enhancement. It discusses the necessity of conducting various toxicity reports at distinct stages of drug growth to make certain safety. These involve one dose, recurring dose, fertility